Gold Prices Dip; Central Bank Purchases Could Boost Demandby Mark Eisenberg 19.06.2024Gold prices dipped amid limited Juneteenth trading. Central bank buying expected to boost demand despite fewer Fed rate cuts. Commodities ...
Nvidia’s Stock Target Raised by Stifel Amid Growth Prospectsby Mark Eisenberg 19.06.2024Nvidia’s growth in high-performance computing and AI drives Stifel to raise price target to $165. Risk factors include trade restrictions ...
HPE to Supply $200M Nvidia Servers for Japan AI Supercomputerby Lilu Anderson 19.06.2024HPE will supply $200M in Nvidia-powered AI servers to Japan's AIST, boosting generative AI technology and positioning Japan as a ...
Day One Biopharma Expands to ADCs with $55M Drug Acquisitionby Lilu Anderson 19.06.2024"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
AI-Developed Magnet Revolutionizes Motors, Ditches Rare Earthsby Lilu Anderson 19.06.2024"Discover how a new AI-designed, rare earth-free magnet by Materials Nexus promises to revolutionize green technologies and accelerate fossil fuel ...
Biotech’s Big Gamble Fails: Insights and Implicationsby Lilu Anderson 18.06.2024Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
Taiwan Weighted Edges Down 0.04% as Ace Pillar Hits Highsby Mark Eisenberg 18.06.2024Taiwan stocks dipped 0.04% Tuesday; Ace Pillar, Universal Inc rise 10%. Crude oil falls, gold up. USD/TWD climbs. Mixed market ...
Danone’s Biotech Platform Boosts Precision Fermentationby Mark Eisenberg 18.06.2024Danone, Michelin, and partners launch a €16M Biotech Open Platform to boost precision fermentation for sustainable, bio-based materials.
Dow Jones Up 0.49% as Apple, Broadcom Hit New Highsby Mark Eisenberg 18.06.2024U.S. stocks surged on October 2, 2023, with the Dow Jones up 0.49%, S&P 500 up 0.77%, and NASDAQ Composite ...
Aerovate Therapeutics Stock Downgraded After Trial Setbackby Mark Eisenberg 17.06.2024Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.